Unveiling Plans on Features and Medical Algorithms Updates that Redefine Personal Health Management

RingConn Smart Ring Impresses at CES 2024: Unveiling Plans on Features and Medical Algorithms Updates that Redefine Personal Health Management The RingConn booth in LVCC North Hall was a buzz of activity, drawing attention from 100+ top-tier media outlets and influencers. This acclaim was paralleled by the interest of the diverse CES audience, many of … Read more

New Apollo eBook Explores Multidisciplinary Patient-Centric Approach to Enterprise Imaging

Discover the future of Enterprise Imaging with Apollo’s approach at RSNA Booth 6810, Nov. 26-29, 2023 CHICAGO, Nov. 25, 2023 /PRNewswire/ — Apollo, a leading provider of enterprise imaging solutions and an Amazon Web Services (AWS) Public Sector Partner (PSP) Program Member, today introduced a new eBook titled Delivering relevant medical images across the continuum … Read more

Ryvu Therapeutics to Present Data on RVU120 at the 2023 American Society of Hematology (ASH) Annual Meeting

Updated data from the Phase I trial of RVU120 in relapsed/refractory acute myeloid leukemia (r/r AML) or high-risk myelodysplastic syndromes (HR-MDS) demonstrate clinically relevant benefit in 50% of evaluable patients Preclinical data support RVU120 as a novel agent for the treatment of patients with lower-risk MDS (LR-MDS) and show cytotoxic and differentiating effects on leukemic stem cells … Read more

New Data from Phase 3 PAPILLON Study Show RYBREVANT® (amivantamab-vmjw) Plus Chemotherapy Resulted in 60 Percent Reduction in Risk of Disease Progression or Death in Patients with Previously Untreated EGFR Exon 20 Insertion Mutation-Positive Non-Small Cell Lung Cancer

Data show the potential impact of RYBREVANT® and chemotherapy combination as first-line treatment for patients with advanced non-small cell lung cancer (NSCLC) with EGFR exon 20 insertion mutations Late-breaking data presented in a Presidential Symposium at 2023 ESMO Congress and simultaneously published in The New England Journal of Medicine MADRID, Oct. 21, 2023 /PRNewswire/ — … Read more

Congreso Anual 2023 de la Academia Europea de Alergia e Inmunología Clínica (EAACI)

– Congreso Anual 2023 de la Academia Europea de Alergia e Inmunología Clínica (EAACI): Concluye con éxito, estableciendo nuevos hitos en alergia e inmunología clínica HAMBURGO, Alemania, 13 de junio de 2023 /PRNewswire/ — La Academia Europea de Alergia e Inmunología Clínica (EAACI) se complace en anunciar la exitosa conclusión de su esperado Congreso Anual, celebrado … Read more

Alexander Shulgin Research Institute Announces Formation of Scientific Advisory Board and Identification of Two Lead Compounds at Psychedelic Science 2023

Lead compounds show remarkable efficacy and safety profiles LAFAYETTE, Calif., June 12, 2023 /PRNewswire/ — Alexander Shulgin Research Institute (ASRI), a pioneering organization in the discovery of next generation psychedelic medicines, announces the identification of two lead compounds currently undergoing late-stage preclinical testing. ASRI plans to disclose further details of their initial lead compounds in a … Read more

AIVITA Biomedical CEO Dr. Hans Keirstead to Deliver Keynote on AI in Healthcare at McKenna Institute Digital Innovation Summit

IRVINE, Calif., June 12, 2023 /PRNewswire/ — AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, today announced that chairman and CEO Dr. Hans Keirstead will deliver a keynote at the Digital Innovation Summit, taking place June 12-13 in St. Andrews, New Brunswick, Canada. Hosted by the University of New Brunswick’s McKenna … Read more

Рекордное количество участников на 20-й выставке CACLP и 3-й выставке CISCE в Нанчане

НАНЧАН, Китай, 12 июня 2023 г. /PRNewswire/ — С 28 по 30 мая 2023 г. в Нанчане, Китай, прошла 20-я выставка Китайской ассоциации клинической лабораторной практики (CACLP) и 3-я Китайская выставка IVD Supply Chain Expo (CISCE), признанные ведущими выставка диагностики in vitro (IVD) в мире. PR1 На выставочной площади в 130 000 кв. м приняли … Read more

Successfully Concludes, Setting New Milestones in Allergy and Clinical Immunology

HAMBURG, Germany, June 12, 2023 /PRNewswire/ — The European Academy of Allergy and Clinical Immunology (EAACI) is pleased to announce the successful conclusion of its highly anticipated Annual Congress, held in Hamburg, Germany, from June 9 to 11. The congress brought together a distinguished gathering of leading experts, healthcare professionals, researchers, and industry representatives from … Read more

Blueprint Medicines Highlights Clinical Progress Across Precision Oncology Pipeline at 2023 ASCO Annual Meeting

— Breadth of pipeline featured in multiple early clinical data presentations, reflecting diversity of fundamental growth drivers across development programs — CAMBRIDGE, Mass., June 3, 2023 /PRNewswire/ — Blueprint Medicines Corporation (Nasdaq: BPMC) today announced clinical data for multiple programs across its precision therapy portfolio at the 2023 American Society of Clinical Oncology (ASCO) Annual … Read more